Glioblastoma:

• RTOG 0825: Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
   

For more information on the above clinical trials: Cheryl Patz, RN, OCN, CCRC, 360.715.4133

Return to previous page

Cancer Services

• St. Joseph Hospital Home
• Cancer Center Home
• All About Cancer
• Make a Gift
• Contact Us

Cancer Committee

• Annual Reports
• Cancer Survival
• Cancer Statistics (PDF)
• Cancer Registry
• Committee Members
• President's Report
• Quality Studies

Cancer Program

• Clinical Trials
• Local Support & Education
• Meet Our Doctors
• Outreach Program
• Radiation Oncology
• Related Services
• Tumor Board